A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says - The New York Times
- A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says The New York Times
- Amylyx will remove ALS drug from the market after failed trial - The Washington Post The Washington Post
- FDA approves much-debated Alzheimer's drug panned by experts The Associated Press
- Why Amylyx is pulling ALS drug Relyvrio from US market after study The Associated Press
- Amylyx to pull ALS drug from market, cut 70% of staff STAT